tirzepatide versus semaglutide side effects caused roughly half as many patients to stop treatment because of gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Tirzepatide vs Semaglutide Side Effects:

This is a big issue for GLP-1 weight-loss drugs, which must be taken for life and as often as daily

Notably, GLP-1RAs slow the transit time of the gastrointestinal (GI) tract and suppress appetite, which could displace nutrient intake and result in mineral and vitamin deficiencies

It's primarily used for men with hypogonadism, where the body doesn't produce enough testosterone

What you read here reflects both the clinical evidence and what we observe directly in practice

This is why many providers suggest taking relief medications at the very first sign of queasiness rather than waiting until the feeling is severe